Sabinsa Corporation granted patent for Tetrahydrocurcuminoids
January 27, 2021
Sabinsa’s Curcumin C3 Reduct ingredient has potential in oral care applications, according to a new clinical trial.
Product focus : Tetrahydrocurcuminoids
November 2007
Sabinsa’s Curcumin C3 Reduct ingredient has potential in oral care applications, according to a new clinical trial.
Tetrahydrocurcuminoids gains increasing acceptance in cosmetic products
November 2007
Sabinsa’s Curcumin C3 Reduct ingredient has potential in oral care applications, according to a new clinical trial.